Spectrum Academy
Keep moving forward
Take advantage of the further education and training opportunities
offered by the Dr. Erkens Consulting Group
Spectrum-Academy
The range of services offered by the Dr. Erkens Consulting Group includes the conception and carrying out of various information and training events as well as education and training programmes. We have bundled this as a further business line of the Dr. Erkens Consulting Group, under the umbrella of the Spectrum Academy.
Subject Areas
The main topics of the Spectrum Academy’s further education and training programme are essentially oriented towards the business areas of the Dr. Erkens Consulting Group.
Analysis | Market Research
Strategy | Implementation
Marketing | Sales
Communication | Education
Organisation | Processes
Innovation | Leadership
Formats
The constantly evolving event portfolio includes:
- Individually designed in-house events at our clients’ premises
- Centrally organized practice-oriented seminars and interactive workshops
- Online events and training courses
Target group
Our offer is specifically aimed at professionals from the healthcare, medical, pharmaceutical, medtech and life sciences industries. It is rounded off by special training courses for employees of companies from the above-mentioned sectors and start-ups, and medical events for patients.
Partners
The Spectrum Academy is supported and co-sponsored by longstanding and trustworthy partner companies such as the be-sign.net agency (which specialises in print and web design) and Aurum Research (which examines the international healthcare market).
Anschrift
Dr. Erkens Consulting Group
Industriestraße 13
64380 Roßdorf
Tel: +49 (0)6154 – 6967 – 944
Mobil +49 (0)179 – 2 41 10 29
info@dr-erkens-consulting.de
Social
News
Dr. Erkens Consulting Group
- Neue Website der Dr. Erkens Consulting Group geht online
Source: Dr. Erkens Consulting Group 09/2020 - Integrierte Pharma-News auf der Dr. Erkens Consulting Group Website
Source: Dr. Erkens Consulting Group 09/2020
Pharma Letter
- July 2024 batch of EMA/CHMP positive opinions
- M&A activity – Fuelling innovation in hard-to-treat CNS disorders
- UK to fund use of Keytruda combo in first-line cancer setting
- Approval of Leqembi in early Alzheimer’s disease rejected by CHMP
- The importance of onshoring and better control of the drug supply chain
Pharma Relations
Pharma Times
- New gut microbiome atlas could offer better treatment for digestive disorders
- Study reveals blood proteins predict risk of developing many diverse diseases
- MRC grants researcher £1.2m to further understand complex secretory processes
- KCL study finds cell ageing could reveal early signs of neurodegenerative disease
- Study suggests targeting amyloid beta production could be promising in AD
PZ online
- Virale Interferenz: Erkältungen könnten Long-Covid-Rückfälle auslösen
- Apotheken-Reformgesetz: SPD-Minister auf Distanz zu Lauterbach
- Mit 78 Jahren : Im Rentenalter eine Apotheke übernehmen
- EMA: Keine Empfehlung für Alzheimer-Antikörper Lecanemab
- Herz-Kreislauf-Erkrankungen: Bei Präventionsthemen sind EU-Minister im Einklang
Our Place on Earth
Kartenbild: OpenStreetMap, ODbL 1.0